Quest Diagnostics (DGX) EV to EBIT (2009 - 2026)

Quest Diagnostics has disclosed EV to EBIT across 18 years of filings, most recently posting 50.26 for Q2 2026.

• In Q2 2026, EV to EBIT rose 10.91% year-over-year to 50.26; the TTM figure through Jun 2026 stood at 14.15 (up 5.18% YoY), while the FY2025 annual figure was 12.03, changed 0.48% from the prior year.
• EV to EBIT came in at 50.26 for Q2 2026 at Quest Diagnostics, down from 54.14 in the prior quarter.
• In the past five years, EV to EBIT ranged from a high of 127.24 in Q4 2022 to a low of 30.08 in Q1 2022.
• Average EV to EBIT over 5 years is 50.75, with a median of 48.24 recorded in 2024.
• Year-over-year, EV to EBIT surged 243.17% in 2022 and plunged 56.86% in 2023.
• Over 5 years, EV to EBIT stood at 127.24 in 2022, then sank by 56.86% to 54.89 in 2023, then decreased by 17.85% to 45.09 in 2024, then grew by 7.6% to 48.51 in 2025, then advanced by 3.61% to 50.26 in 2026.
• Per Business Quant data, the three most recent EV to EBIT figures were 50.26 in Q2 2026, 54.14 in Q1 2026, and 48.51 in Q4 2025.